Rosuvastatin for the prevention of venous thromboembolism: A pooled analysis of the HOPE-3 and JUPITER randomized controlled trials

Rosuvastatin for the prevention of venous thromboembolism: A pooled analysis of the HOPE-3 and JUPITER randomized controlled trials

Aims: To examine the association between rosuvastatin and VTE risk, and whether effects vary in different subpopulations stratified by key demographic, cardiovascular disease (CVD) risk factors, and other risk factors associated with VTE. Methods and results: An individual participant data meta-Anal...

Full description

Bibliographic Details
Main Authors: Eikelboom, J. (Author), Glynn, R. (Author), Joseph, P. (Author), Lonn, E. (Author), Macfadyen, J. (Author), Ramasundarahettige, C. (Author), Ridker, P. (Author), Yusuf, S. (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
aged
Aged
human
Humans
hydroxymethylglutaryl coenzyme A reductase inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors
lung embolism
male
Male
meta analysis
Pulmonary Embolism
randomized controlled trial (topic)
Randomized Controlled Trials as Topic
risk factor
Risk Factors
rosuvastatin
Rosuvastatin Calcium
Statin
venous thromboembolism
Venous thromboembolism
Venous Thromboembolism
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items